CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE
🏢 View company profile →31Patents
31Active
31Granted
52Portfolio score
Filing activity: Jan 25, 2012 → Sep 27, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10822415B2 | Methods for enhancing the potency of the immune checkpoint inhibitors | Physics | 5 | Active |
| US10918737B2 | Methods and pharmaceutical composition for the treatment of cancer | Chemistry; Metallurgy | 1 | Active |
| USD797831S1 | Microscope | General | 1 | Active |
| US9410955B2 | Method for predicting the risk of developing a colonic neoplasia | Physics | 0 | Active |
| US10781293B2 | Process for preparing biocompatible and biodegradable porous three-dimensional polymer matrices and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11078277B2 | Methods and pharmaceutical compositions for enhancing CD8+ T cell-dependent immune responses in subjects suffering from cancer | Physics | 0 | Active |
| US9851358B2 | Methods and pharmaceutical compositions for preventing or reducing metastatic dissemination | Physics | 0 | Active |
| US10426818B2 | Method and pharmaceutical composition for use in the treatment of diabetes | Human Necessities | 0 | Active |
| US10188666B2 | Dendrogenin A and antineoplastic agents for the treatment of chemosensitive or chemoresistant tumors | Human Necessities | 0 | Active |
| US12011466B2 | Modified Escherichia coli strain Nissle and treatment of gastrointestinal disorder | Emerging Cross-Sectional Technologies | 0 | Active |
| US9052326B2 | Method for assessing a subject's risk of having a cardiovascular disease | Physics | 0 | Active |
| US11471538B2 | Methods and pharmaceutical compositions for the treatment of cancers associated with activation of the MAPK pathway | Chemistry; Metallurgy | 0 | Active |
| US11896649B2 | Methods and pharmaceutical compositions for the treatment of post-operative cognitive dysfunction | Human Necessities | 0 | Active |
| US10760135B2 | Methods for predicting pancreatic cancer treatment response | Physics | 0 | Active |
| US11061037B2 | Diagnostic of heart failure | Physics | 0 | Active |
| US11484577B2 | Methods and pharmaceutical compositions for the treatment of post-operative cognitive dysfunction | Human Necessities | 0 | Active |
| US11376269B2 | Pharmaceutical compositions for the treatment of chemoresistant acute myeloid leukemia (AML) | Human Necessities | 0 | Active |
| US10401365B2 | Inhibition of chemokine CCL7 or receptor CCR3 of same for the treatment and diagnosis of prostate cancer | Physics | 0 | Active |
| US10144772B2 | Method for treating melanoma | Physics | 0 | Active |
| US12023420B2 | Vascular stent with antithrombotic properties | Human Necessities | 0 | Active |
| US9945871B2 | Method for measuring the level of circulating inhibitory factor 1 protein in a subject measuring the level of circulating inhibitory factor 1 (IF1) protein in a subject | Physics | 0 | Active |
| US11457900B2 | Microdevice for the in vivo capture of circulating cellular biomarkers | Human Necessities | 0 | Active |
| US10709776B2 | Method for producing outer membrane vesicles | Physics | 0 | Active |
| US11912645B2 | Lipopeptide compounds for the treatment of pain disorders | Human Necessities | 0 | Active |
| US11186634B2 | Antibodies targeting tumor associated macrophages and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.